[ad_1]
TJ / ALmedicam
Metastatic. The decision was published Thursday in the Diário da Justiça Eletrônico (4).
In action, the public defender argued that the unified health system (SUS) does not allow the drug to be available and that there is no drug. Another medicine that can replace it. He also stated that the patient had already undergone palliative treatment for 12 cycles, but the disease progressed with progression to the bone. A second palliative line has been initiated and the patient is in the second cycle of treatment with the drug Bevaczumabe.
In his ruling, Judge Celyrio Adamastor pointed out that the state can not limit itself to providing the discussed treatment nor impeding access to health, especially the low-income population. However, the patient must present, every six months, a price attesting to the need for continuity of treatment.
"The documents on file show the need to provide the drug because of the serious health condition of the petitioner, who is likely to have a greater benefit, namely life, health and safety. he does not receive emergency care folded The plaintiff is 58 years old and has metastatic colon cancer for the liver and peritoneum, which has evolved in the bone, causing various complications such as pain and limitations , causing progressive damage to his health and impeding his daily life. "
Related Matter to Process No. 0800116-72.2018.8.02.9002
Source link
